Frequency and factors leading to recurrent pre-eclampsia

Journal of the Pakistan Medical Association

Volumn 65, Issue 11, 2015, Pages 1173-1177

  Emanuel, Mirab ^a   Butt, Sofia ^b  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

BMI; Chronic hypertension; Gestational diabetes; Recurrent preeclampsia

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; FREQUENCY ANALYSIS; GESTATIONAL AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MIDDLE AGED; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; QUESTIONNAIRE; RISK FACTOR; DIABETES, GESTATIONAL; PAKISTAN; PRE-ECLAMPSIA; PREGNANCY; RECURRENT DISEASE; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; PAKISTAN; PRE-ECLAMPSIA; PREGNANCY; RECURRENCE; RISK FACTORS; YOUNG ADULT;

EID: 84946434017     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Anderson UD, Olsson MG, Kristensen KH, Åkerström B, Hansson SR. Biochemical markers to predict preeclampsia. Placenta. 2012; 33: S42-7.
2. Bramham K, Briley AL, Seed P, Poston L, Shennan AH, Chappell LC. Adverse maternal and perinatal outcomes in women with previous preeclampsia: a prospective study. Am J Obstet Gynecol. 2011; 204: 512. e1-9.
3. Ghulmiyyah L, Sibai B. Maternal mortality for preeclampsia/eclampsia. Semin Perinatol. 2012; 36: 56-9.
4. Shennan A. Hypertensive disorder. In: Keith Edmonds eds. Dewhurst 7th edition. Obstetrics and Gynaecology. London/UK: Blackwell Publishing, 2007; pp 227.
5. Sharma JB, Mittal S. Prevention of preeclampsia. Progress Obstet Gynaecol. 172006; 10: 141.
6. Hernández-Díaz S, Toh S, Cnattingius S. Risk of preeclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009; 338: b2255.
7. Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity and interval between births. Am J Obstet Gynecol. 2008; 199: 55. e1-7.
8. McDonald S, Best C, Lam K. The recurrence risk of severe denovo preeclampsia in singleton pregnancies; a population based cohort. BJOG. 2009; 116: 1578-84.
9. Facchinetti F, Marozio L, Frusca T, Grandone E, Venturini P, Tiscia GL, et al. Maternal thrombophilia and risk of recurrence of preeclampsia. Am J Obstet Gynecol. 2009; 200: 46. e1-5.
10. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002; 346: 33-8.
11. Mendilcioglu I, Trak B, Uner M, Umit S, Kucukosmanglu M. Recurrent preeclampsia and perinatal outcome; a study of women with recurrent preeclampsia compared with women with preeclampsia who remained normotensive during their prior pregnancies. Acta Obstet Gynecol Scand. 2004; 83: 1044-8.
12. Wildschut HIF, Prepregnancy Antecedents of A High Risk Pregnancy. In: David James, Philip Steer, Carl Weiner, Bernard Gonik eds. High Risk Pregnancy. 3rd Edition. Saunders Elsevier Publisher, 2005; pp 19.
13. Mostello D, Catlin TK, Roman L, Holcomb WL Jr, Leet T, Preeclampsia in the parous women: who is at risk?Am J Obstet Gynecol. 2002; 187: 425-9.
14. Code-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. Effects of birth spacing onmaternal health: a systematic review. Am J Obstet Gynecol. 2007; 196: 297-308.
15. Roberts JM, Bodnar LM, Patrick TE, Powers RW. The Role of obesity in preeclampsia. Pregnancy Hypertens. 2011; 1: 6-16.
16. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: A systematic overview. Epidemiology. 2003; 14: 368-74.
17. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004; 103: 219-24.
18. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: The potential role of inflammation. Obstet Gynecol. 2001; 98: 757-62.
19. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998; 179: 1359-75.
20. Kaaja RJ, Pöyhönen-Alho MK. Insulin resistance and sympathetic overactivity in women. J Hypertens. 2006; 24: 131-41.
21. Emery SP, Levine RJ, Qian C, Ewell MG, England LJ, Yu KF, etal. CPEPstudygroup. Twenty-four-hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of preeclampsia and gestational hypertension. BJOG. 2005; 112: 1479-85.
22. Mostello D, Jen Change J, Allen J, Luehr L, Shyken J, Lee T. Recurrent preeclampsia: the effect of weight change between pregnancies. Obstet Gynecol. 2010; 116: 667-72.
23. Bhattacharya S, Campbell DM, Smith NC. Preeclampsia is the second pregnancy: Does previous outcome matter: Eur J Obstet Gynecol Reprod Biol. 2009; 144: 130-4.
24. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002; 100: 369-77.
25. Maruotti GM, Sarno L, Napolitano R, Mazzarelli LL, Quaglia F, Capone A, etal. Preeclampsia in women with chronic kidney disease. J Matern Fetal Neonatal Med. 2012; 25: 1367-9.
26. Casiola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulantactivity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1996; 93: 1624-9.
27. van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MM, von Blomberg BM, etal. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol. 1999; 180: 1146-50.
28. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol. 2002; 101: 6-14.
29. Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol. 2003; 1: 111.